文献速递甲状腺疾病

促甲状腺激素而非促甲状腺抗体在人甲状腺细胞中诱导基因表达的双相调节

Thyrotropin, but Not Thyroid-Stimulating Antibodies, Induces Biphasic Regulation of Gene Expression in Human Thyrocytes.
PubMed 文献 · Thyroid · 2020-01-28

本研究在人甲状腺细胞原代培养中比较促甲状腺激素(TSH)与两种单克隆促甲状腺抗体(KSAb1、M22)介导的TSH受体信号。TSH低剂量升高、高剂量(>1 mU/mL)降低TSHR、TG、TPO、NIS、DIO2基因表达,呈倒U型剂量反应曲线;TSAb则呈单调剂量反应曲线,高剂量时平台化。

要点

  • TSH低剂量升高、高剂量(>1 mU/mL)降低甲状腺特异基因表达,呈倒U型曲线
  • TSH对甲状腺球蛋白分泌的调节也呈倒U型剂量反应曲线
  • KSAb1与M22对TSHR、TG、TPO、NIS、DIO2基因表达及分泌TG呈单调剂量反应曲线,高剂量时平台化

核心结论

  • TSH对TSHR的生理性激活在人甲状腺细胞原代培养中表现为可能抑制甲状腺细胞过度刺激的调节机制,而促甲状腺抗体不表现双相调节。
  • 作者认为,KSAb1与M22可能不能代表Graves病患者的全部促甲状腺抗体,但促甲状腺抗体对TSHR持续强刺激、不因高抗体水平而减弱,可能促进Graves甲状腺功能亢进症中甲状腺细胞的慢性刺激。

研究设计与样本

  • 研究在人甲状腺细胞原代培养中,用定量逆转录聚合酶链反应检测TSH或两种单克隆促甲状腺抗体KSAb1与M22刺激后TG、TPO、DIO2、NIS和TSHR的mRNA水平。
  • 用酶联免疫吸附试验比较TSH与促甲状腺抗体激活TSHR后分泌的TG蛋白,并用荧光激活细胞分选测定TSHR细胞表面表达。

主要发现

  • TSH低剂量升高、高剂量(>1 mU/mL)降低TSHR、TG、TPO、NIS和DIO2的基因表达水平。
  • TSH对信号的双相效应不是由细胞表面TSHR下调所致,该钟形双相剂量反应曲线称为倒U型剂量反应曲线(IUDRC)。
  • TSH诱导的TG分泌调节也呈IUDRC。
  • KSAb1与M22诱导的TSHR、TG、TPO、NIS和DIO2基因表达调节及分泌TG呈单调剂量反应曲线,在高剂量激活性抗体时平台化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出KSAb1与M22可能不能代表Graves病患者的全部促甲状腺抗体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Thyrotropin (TSH) and thyroid-stimulating antibodies (TSAbs) activate TSH receptor (TSHR) signaling by binding to its extracellular domain. TSHR signaling has been studied extensively in animal thyrocytes and in engineered cell lines, and differences in signaling have been observed in different cell systems. We, therefore, decided to characterize and compare TSHR signaling mediated by TSH and monoclonal TSAbs in human thyrocytes in primary culture. Methods: We used quantitative reverse transcription-polymerase chain reaction to measure mRNA levels of thyroid-specific genes thyroglobulin (TG), thyroperoxidase (TPO), iodothyronine deiodinase type 2 (DIO2), sodium-iodide symporter (NIS), and TSHR after stimulation by TSH or two monoclonal TSAbs, KSAb1 and M22. We also compared secreted TG protein after TSHR activation by TSH and TSAbs using an enzyme-linked immunosorbent assay. TSHR cell surface expression was determined using fluorescence activated cell sorting (FACS). Results: We found that TSH at low doses increases and at high doses (>1 mU/mL) decreases levels of gene expression for TSHR, TG, TPO, NIS, and DIO2. The biphasic effect of TSH on signaling was not caused by downregulation of cell surface TSHRs. This bell-shaped biphasic dose-response curve has been termed an inverted U-shaped dose-response curve (IUDRC). An IUDRC was also found for TSH-induced regulation of TG secretion. In contrast, KSAb1- and M22-induced regulation of TSHR, TG, TPO, NIS, and DIO2 gene expression, and secreted TG followed a monotonic dose-response curve that plateaus at high doses of activating antibody. Conclusions: Our data demonstrate that the physiological activation of TSHRs by TSH in primary cultures of human thyrocytes is characterized by a regulatory mechanism that may inhibit thyrocyte overstimulation. In contrast, TSAbs do not exhibit biphasic regulation. Although KSAb1 and M22 may not be representative of all TSAbs found in patients with Graves' disease, we suggest that persistent robust stimulation of TSHRs by TSAbs, unrelieved by a decrease at high TSAb levels, fosters chronic stimulation of thyrocytes in Graves' hyperthyroidism.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Jang D, Morgan SJ, Klubo-Gwiezdzinska J, et al. Thyrotropin, but Not Thyroid-Stimulating Antibodies, Induces Biphasic Regulation of Gene Expression in Human Thyrocytes. Thyroid. 2020. PMID: 31805824. doi:10.1089/thy.2019.0418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。